Altrius Capital Management Inc Has $3.81 Million Stock Position in The Cigna Group (NYSE:CI)

Altrius Capital Management Inc grew its position in The Cigna Group (NYSE:CI) by 0.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,714 shares of the health services provider’s stock after purchasing an additional 53 shares during the quarter. Altrius Capital Management Inc’s holdings in The Cigna Group were worth $3,807,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Bogart Wealth LLC boosted its stake in shares of The Cigna Group by 104.5% in the 3rd quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 46 shares during the last quarter. OFI Invest Asset Management bought a new position in The Cigna Group during the third quarter worth $26,000. Fortitude Family Office LLC bought a new position in The Cigna Group during the fourth quarter worth $29,000. VisionPoint Advisory Group LLC boosted its stake in The Cigna Group by 112.2% during the third quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock worth $30,000 after acquiring an additional 55 shares in the last quarter. Finally, Pacifica Partners Inc. lifted its stake in shares of The Cigna Group by 73.2% in the fourth quarter. Pacifica Partners Inc. now owns 142 shares of the health services provider’s stock valued at $43,000 after buying an additional 60 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

The Cigna Group Stock Performance

NYSE:CI traded up $1.97 on Monday, reaching $356.44. 1,073,617 shares of the company’s stock were exchanged, compared to its average volume of 1,564,747. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.67. The firm has a market cap of $104.21 billion, a price-to-earnings ratio of 20.38, a P/E/G ratio of 1.09 and a beta of 0.56. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71. The stock has a fifty day simple moving average of $349.88 and a 200-day simple moving average of $318.15.

The Cigna Group (NYSE:CI) last issued its earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, topping analysts’ consensus estimates of $6.54 by $0.25. The firm had revenue of $51.15 billion during the quarter, compared to analyst estimates of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The company’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter last year, the business earned $4.96 earnings per share. As a group, sell-side analysts predict that The Cigna Group will post 28.36 earnings per share for the current year.

The Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be given a dividend of $1.40 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.57%. The Cigna Group’s dividend payout ratio (DPR) is currently 32.20%.

Insider Transactions at The Cigna Group

In related news, CEO David Cordani sold 31,209 shares of the stock in a transaction on Monday, March 25th. The stock was sold at an average price of $355.17, for a total value of $11,084,500.53. Following the transaction, the chief executive officer now owns 348,054 shares of the company’s stock, valued at $123,618,339.18. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CEO David Cordani sold 31,209 shares of the stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $355.17, for a total transaction of $11,084,500.53. Following the completion of the sale, the chief executive officer now directly owns 348,054 shares in the company, valued at $123,618,339.18. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Eric P. Palmer sold 1,017 shares of the stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.26, for a total transaction of $340,959.42. Following the sale, the insider now owns 45,564 shares of the company’s stock, valued at $15,275,786.64. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 114,144 shares of company stock valued at $39,296,330. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft raised shares of The Cigna Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $355.00 to $370.00 in a research note on Thursday, February 1st. Mizuho increased their target price on shares of The Cigna Group from $360.00 to $370.00 and gave the company a “buy” rating in a report on Monday, February 5th. StockNews.com upgraded shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Thursday, March 14th. Wells Fargo & Company increased their target price on shares of The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a report on Tuesday, February 6th. Finally, Sanford C. Bernstein upgraded shares of The Cigna Group from a “market perform” rating to an “outperform” rating and increased their target price for the company from $330.00 to $372.00 in a report on Thursday, January 4th. Two investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $362.14.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.